SB
Sarai Bronfeld
Partner at NFX
SB
Sarai Bronfeld
Partner at NFX
Tel Aviv-Yafo, Tel Aviv District
Overview
Work Experience
Board Member
2024 - Current
Partner
2024
Principal
2022 - 2024
Associate
2021 - 2022
$450M pre-seed and seed only Venture Capital. SF\IL-based. ~$1B AUM.
Board Member
2024
Judge\Mentor
2021
Business Consultant
2021 - 2024
Investor
2018 - 2021
Late-stage and pre IPOs. $100M AUM.
Head Of Business Operations
2019 - 2020
Business Operations
2019 - 2020
CSO
2018 - 2020
Research Scientist
2017 - 2019
Research focused on the endocrine and paracrine aspects of pancreatic cancer development and tumor metabolism. Master thesis on Klotho Gene, hormone that links longevity to cancer protection. Thesis Supervisor: Prof. Ido Wolf, Director of Oncology Department.